Cargando…

An Evaluation of Hepatotoxicity in Breast Cancer Patients Receiving Injection Doxorubicin

BACKGROUND: Hepatic dysfunction in the cancer unit has a significant impact on patient outcomes. The therapeutic application of anthracycline antibiotics are limited by side-effects mainly myelosuppression, chronic cardiotoxicity, and hepatotoxicity. AIM: To assess the risk of Hepatotoxicity in brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damodar, G, Smitha, T, Gopinath, S, Vijayakumar, S, Rao, YA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952301/ https://www.ncbi.nlm.nih.gov/pubmed/24669335 http://dx.doi.org/10.4103/2141-9248.126619

Ejemplares similares

Reasons for Low Quality of Life in South Indian Cancer Patient Population: A Prospective Observational Study
por: Damodar, G., et al.
Publicado: (2014)

Endogenous FGF1 Deficiency Aggravates Doxorubicin-Induced Hepatotoxicity
por: Gu, Chunjie, et al.
Publicado: (2023)

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
por: Kim, Gun Min, et al.
Publicado: (2019)

Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis
por: Gu, Yue, et al.
Publicado: (2018)

The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
por: Rašković, Aleksandar, et al.
Publicado: (2011)

Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2020)

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity
por: Sedeman, Megan, et al.
Publicado: (2022)

Machine Learning Approaches to Predict Hepatotoxicity Risk in Patients Receiving Nilotinib
por: Kim, Jung-Sun, et al.
Publicado: (2021)

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
por: Kim, Chang Gon, et al.
Publicado: (2016)

Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy
por: Huang, Ping, et al.
Publicado: (2022)

Creatine Supplementation Potentiates Exercise Protective Effects against Doxorubicin-Induced Hepatotoxicity in Mice
por: Costa Godinho, Loriane R. L., et al.
Publicado: (2023)

Taurine Protects Doxorubicin-Induced Hepatotoxicity via Its Membrane-Stabilizing Effect in Rats
por: Gedikli, Esra, et al.
Publicado: (2023)

Study of the effect of bezafibrate with ginkgo biloba extracts in an animal model of hepatotoxicity induced by doxorubicin
por: Abdalla, Zhwan Azad, et al.
Publicado: (2023)

Hypolipidemic Effect of Psidium guajava Leaf Extract Against Hepatotoxicity in Rats
por: Vijayakumar, K., et al.
Publicado: (2018)

Protective effect of carvedilol alone and coadministered with diltiazem and prednisolone on doxorubicin and 5‐fluorouracil‐induced hepatotoxicity and nephrotoxicity in rats
por: Akindele, Abidemi J., et al.
Publicado: (2018)

Protective effect of aqueous leaf extracts of Chromolaena odorata and Tridax procumbens on doxorubicin-induced hepatotoxicity in Wistar rats
por: Ikewuchi, Catherine C., et al.
Publicado: (2021)

Effects of a Yoga Program on Mood States, Quality of Life, and Toxicity in Breast Cancer Patients Receiving Conventional Treatment: A Randomized Controlled Trial
por: Rao, Raghavendra Mohan, et al.
Publicado: (2017)

Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
por: Wang, Ling-Cheng, et al.
Publicado: (2020)

HEPATOTOXICITY OF EUGENOL
por: Soundran, Vijaya, et al.
Publicado: (1994)

A Case of Hepatotoxicity After Receiving a COVID-19 Vaccine
por: Alqarni, Muath M, et al.
Publicado: (2021)

Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial
por: Masuda, Norikazu, et al.
Publicado: (2015)

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment
por: Blaes, Anne, et al.
Publicado: (2015)

Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction
por: Mekonnen, Ayal Tsegaye, et al.
Publicado: (2022)

Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products
por: Patel, Dhavalkumar N., et al.
Publicado: (2015)

Thyme Oil and Thymol Counter Doxorubicin-Induced Hepatotoxicity via Modulation of Inflammation, Apoptosis, and Oxidative Stress
por: Ahmed, Osama M., et al.
Publicado: (2022)

Chronic Manganese Administration with Longer Intervals Between Injections Produced Neurotoxicity and Hepatotoxicity in Rats
por: Fan, Xi-Min, et al.
Publicado: (2020)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer
por: Lin, Ying, et al.
Publicado: (2014)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)

Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer()()
por: Cheng, Menglin, et al.
Publicado: (2017)

Thioredoxin-1 Activation by Pterostilbene Protects Against Doxorubicin-Induced Hepatotoxicity via Inhibiting the NLRP3 Inflammasome
por: Tan, Shiqing, et al.
Publicado: (2022)

Hepatotoxicity and Associated Risk Factors in HIV-Infected Patients Receiving Antiretroviral Therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia
por: Mulu, Wondemagegn, et al.
Publicado: (2013)

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
por: Li, Jieli, et al.
Publicado: (2020)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin
por: Mankhatitham, W, et al.
Publicado: (2010)

Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy
por: Khositseth, Anant, et al.
Publicado: (2011)

The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
por: Coyle, Jayme P, et al.
Publicado: (2015)

Preclinical safety and hepatotoxicity evaluation of biomineralized copper sulfide nanoagents
por: Xia, Ya-Nan, et al.
Publicado: (2022)

Lead-induced Hepatotoxicity and Evaluation of Certain Anti-stress Adaptogens in Poultry
por: Kumar, M. Ratan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3iciuatvtudosi8kdefqkflit8